We investigated the levels of CEA, CA 242,CA 19-9 and the total antioxidant
status in 45 patients with colorectal cancer. Blood samples were obtained
from 24 patients in the early postoperative phase, 16 patients in the late
postoperative phase and 5 patients with recurrent disease. Statistical sign
ificances were calculated in each group by the Mann-Whitney U test. No mean
ingful difference was observed between the control and early or late postop
erative groups. However, serum CEA levels were significantly different betw
een the control and recurrent groups (p < 0.001). A meaningful difference w
as also observed between the recurrent and early (p < 0.001) and late posto
perative (p = 0.015) groups, respectively. Our study shows that CEA is the
only tumor marker that can be used in monitoring colorectal cancer patients
.